Enhanced rectal absorption of insulin-loaded Pluronic® F-127 gels containing unsaturated fatty acids

被引:45
作者
Barichello, JM
Morishita, M
Takayama, K
Chiba, Y
Tokiwa, S
Nagai, T
机构
[1] Hoshi Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
[2] Nippon Suisan Kaisya, Cent Res Lab, Hachioji, Tokyo 1920906, Japan
关键词
insulin; Pluronic F-127 gels; rectal absorption; unsaturated fatty acids; hypoglycermic effect; sustained release;
D O I
10.1016/S0378-5173(99)00090-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to prepare and to evaluate Pluronic F-127 (PF127) gel containing unsaturated fatty acids such as oleic acid (18:1), eicosapentaenoic acid (20:5) and docosahexaenoic acid (22:6) as a potential formulation for rectal delivery of insulin. The hypoglycemic effect of insulin was examined following rectal administration of the various formulations in normal rats. Rectal insulin absorption was markedly enhanced, and marked hypoglycemia was induced by all PF127 gels (insulin dose, 5 U/kg) containing different unsaturated fatty acids. PF127 gels containing unsaturated fatty acids presented low t(max) mean values indicating that the absorption of insulin occurred very rapidly in the rectum. The relative hypoglycemic efficacy of PF127 gel formulations containing fatty acids such as oleic acid, eicosapentaenoic (EPA) and docosahexaenoic (DHA) were 28.4 +/- 8.1, 26.8 +/- 14.3 and 23.1 +/- 5.7%, respectively. The finding demonstrated that 20% PF127 gels containing unsaturated fatty acids are potential formulations for rectal delivery of insulin. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 41 条
[11]   RECTAL ABSORPTION OF INSULIN SUPPOSITORIES IN RABBITS [J].
ICHIKAWA, K ;
OHATA, I ;
MITOMI, M ;
KAWAMURA, S ;
MAENO, H ;
KAWATA, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (05) :314-318
[12]   SUSTAINED DELIVERY OF INTERLEUKIN-2 FROM A POLOXAMER-407 GEL MATRIX FOLLOWING INTRAPERITONEAL INJECTION IN MICE [J].
JOHNSTON, TP ;
PUNJABI, MA ;
FROELICH, CJ .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :425-434
[13]  
JUHASZ J, 1991, EUR J PHARM BIOPHARM, V37, P262
[14]   Controlled release of human growth hormone following subcutaneous administration in dogs [J].
Katakam, M ;
Ravis, WR ;
Golden, DL ;
Banga, AK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (01) :53-58
[15]  
LAMPE MA, 1983, J LIPID RES, V24, P120
[16]   Percutaneous absorption and histopathology of a poloxamer-based formulation of capsaicin analog [J].
Lee, BJ ;
Lee, TS ;
Cha, BJ ;
Kim, SH ;
Kim, WB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 159 (01) :105-114
[17]   EFFECT OF RECTAL SUPPOSITORY FORMULATION ON THE RELEASE OF INSULIN AND ON THE GLUCOSE PLASMA-LEVELS IN DOGS [J].
LIVERSIDGE, GG ;
NISHIHATA, T ;
ENGLE, KK ;
HIGUCHI, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (01) :87-95
[18]   Diffusion studies of methotrexate in Carbopol and Poloxamer gels [J].
Lu, GW ;
Jun, HW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) :1-9
[19]   EFFECT OF POLOXAMER 407 GEL ON THE MIOTIC ACTIVITY OF PILOCARPINE NITRATE IN RABBITS [J].
MILLER, SC ;
DONOVAN, MD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 12 (2-3) :147-152
[20]  
MIYAZAKI S, 1984, CHEM PHARM BULL, V32, P4205